MNMD
Price
$6.53
Change
-$0.02 (-0.31%)
Updated
Jun 30, 04:17 PM (EDT)
Capitalization
494.87M
45 days until earnings call
PBM
Price
$5.37
Change
+$0.46 (+9.37%)
Updated
Jun 30, 01:29 PM (EDT)
Capitalization
2.86M
Interact to see
Advertisement

MNMD vs PBM

Header iconMNMD vs PBM Comparison
Open Charts MNMD vs PBMBanner chart's image
Mind Medicine (MindMed)
Price$6.53
Change-$0.02 (-0.31%)
Volume$266
Capitalization494.87M
Psyence Biomedical
Price$5.37
Change+$0.46 (+9.37%)
Volume$300
Capitalization2.86M
MNMD vs PBM Comparison Chart in %
Loading...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNMD vs. PBM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNMD is a Buy and PBM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (MNMD: $6.55 vs. PBM: $4.91)
Brand notoriety: MNMD and PBM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNMD: 186% vs. PBM: 7%
Market capitalization -- MNMD: $494.87M vs. PBM: $2.86M
MNMD [@Biotechnology] is valued at $494.87M. PBM’s [@Biotechnology] market capitalization is $2.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNMD’s FA Score shows that 1 FA rating(s) are green whilePBM’s FA Score has 1 green FA rating(s).

  • MNMD’s FA Score: 1 green, 4 red.
  • PBM’s FA Score: 1 green, 4 red.
According to our system of comparison, PBM is a better buy in the long-term than MNMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNMD’s TA Score shows that 3 TA indicator(s) are bullish while PBM’s TA Score has 2 bullish TA indicator(s).

  • MNMD’s TA Score: 3 bullish, 6 bearish.
  • PBM’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, PBM is a better buy in the short-term than MNMD.

Price Growth

MNMD (@Biotechnology) experienced а -7.09% price change this week, while PBM (@Biotechnology) price change was +3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.84%. For the same industry, the average monthly price growth was +33.18%, and the average quarterly price growth was +7.04%.

Reported Earning Dates

MNMD is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+3.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNMD($495M) has a higher market cap than PBM($2.86M). MNMD YTD gains are higher at: -5.891 vs. PBM (-70.803). MNMD has more cash in the bank: 212M vs. PBM (1.93M). PBM has less debt than MNMD: PBM (2.5M) vs MNMD (22M).
MNMDPBMMNMD / PBM
Capitalization495M2.86M17,284%
EBITDA-75.18MN/A-
Gain YTD-5.891-70.8038%
P/E RatioN/A0.12-
Revenue0N/A-
Total Cash212M1.93M10,967%
Total Debt22M2.5M880%
FUNDAMENTALS RATINGS
MNMD: Fundamental Ratings
MNMD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MNMDPBM
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCECX32.980.52
+1.60%
Fidelity Advisor Consumer Discret C
JIUCX16.760.14
+0.84%
JPMorgan Developed International Value C
PJECX14.800.05
+0.34%
PGIM US Real Estate C
SIEYX13.850.04
+0.29%
Saratoga International Equity A
FRIOX11.89N/A
N/A
Fidelity Advisor Real Estate Income C

PBM and

Correlation & Price change

A.I.dvisor tells us that PBM and ATHA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBM and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBM
1D Price
Change %
PBM100%
-3.89%
ATHA - PBM
30%
Poorly correlated
-2.64%
SLRX - PBM
29%
Poorly correlated
-0.01%
MNMD - PBM
27%
Poorly correlated
-2.82%
CRBU - PBM
26%
Poorly correlated
-6.67%
PRME - PBM
25%
Poorly correlated
-8.68%
More